Long-term cardiovascular outcomes of COVID-19
The study “Long-term cardiovascular outcomes of COVID-19” conducted by Yan Xie, Evan Xu, Benjamin Bowe, and Ziyad Al-Aly utilized U.S. Department of Veterans Affairs healthcare databases to investigate the cardiovascular risks and burdens in individuals post-COVID-19 recovery. The study included a cohort of 153,760 COVID-19 patients and two control groups: contemporary controls (5,637,647 individuals) and historical controls (5,859,411 individuals) to compare the incidence of cardiovascular diseases.
Key Findings of the Study:
- Increased Risk of Cardiovascular Diseases: Individuals with COVID-19 exhibited increased risks for various cardiovascular diseases, including cerebrovascular disorders, dysrhythmias, ischemic and non-ischemic heart diseases, pericarditis, myocarditis, heart failure, and thromboembolic diseases, even after the initial 30 days following infection.
- Specific Cardiovascular Outcomes:
- Increased risks of stroke and transient ischemic attacks (TIAs).
- Elevated risks of dysrhythmias like atrial fibrillation, sinus tachycardia, sinus bradycardia, ventricular arrhythmias, and atrial flutter.
- Higher incidence of inflammatory diseases of the heart or pericardium, including pericarditis and myocarditis.
- Increased cases of ischemic heart diseases such as acute coronary disease, myocardial infarction, ischemic cardiomyopathy, and angina.
- Other cardiovascular disorders observed included heart failure, non-ischemic cardiomyopathy, cardiac arrest, and cardiogenic shock.
- Elevated risks of thromboembolic disorders like pulmonary embolism, deep vein thrombosis, and superficial vein thrombosis.
- Notably, the study also reported increased risks for major adverse cardiovascular events (MACE) and any cardiovascular outcome.
- Subgroup Analyses: The study observed that the risks of these cardiovascular outcomes were consistent across various subgroups based on factors like age, race, sex, obesity, smoking, hypertension, diabetes, chronic kidney disease, and pre-existing cardiovascular disease.
- Implications for Post-COVID Care: The findings suggest the importance of including cardiovascular health and disease monitoring in the care pathways for individuals recovering from COVID-19, considering the substantial risks and burdens of cardiovascular diseases identified in this group.
- Possible Mechanisms: The study discussed potential mechanisms driving these cardiovascular complications, including direct viral invasion of cardiomyocytes, endothelial cell infection, complement activation, downregulation of ACE2, and dysregulation of the renin-angiotensin-aldosterone system, among others.
- Strengths and Limitations: The study’s strengths included its large cohort size, use of comprehensive and varied cardiovascular outcomes, and rigorous methodological approach. However, limitations such as the demographic composition (primarily White and male) and potential for misclassification bias and residual confounding were acknowledged. Additionally, the dynamic nature of the pandemic and evolving treatment strategies may affect the generalizability of these findings over time.
In summary, the study provides significant insights into the long-term cardiovascular risks associated with COVID-19, highlighting the need for comprehensive cardiovascular monitoring and care in individuals recovering from the disease.
Read More: https://www.nature.com/articles/s41591-022-01689-3